High expression of TROP2 correlates with poor prognosis in pancreatic cancer

Pancreatic cancer is one of the most devastating human malignancies. Despite considerable research efforts, it remains resistant to almost all available treatment regimens. The human trophoblast cell-surface antigen, TROP2, was found to be strongly expressed in a variety of human epithelial cancers,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fong, D, Moser, P, Krammel, C, Gostner, J M, Margreiter, R, Mitterer, M, Gastl, G, Spizzo, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570520/
https://www.ncbi.nlm.nih.gov/pubmed/18813308
http://dx.doi.org/10.1038/sj.bjc.6604677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2570520/
https://www.ncbi.nlm.nih.gov/pubmed/18813308
http://dx.doi.org/10.1038/sj.bjc.6604677

Ejemplares similares